EUVIMEDEUVIMED entdecken
Crossref

Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data

Nadine Gunder, Thomas Hummel, Mandy Cuevas

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S315

DOI: 10.1055/s-0044-1785064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Nadine Gunder und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In the past years, three monoclonal antibodies have been approved in Germany for the treatment of the severe form of CRSwNP. This study investigated the effectiveness and safety of dupilumab, omalizumab and mepolizumab in clinical use. Material & Methods To date, 93 adults with severe CRSwNP and inadequate response to intranasal corticosteroids have been treated with dupilumab (n=63), mepolizumab (n=7) or omalizumab (n=23) at our clinic. The observation period was up to 24 months (11/2019-11/2023). Nasal polyp score (NPS), quality of life (QoL, SNOT-22) and olfactory function (OF, Sniffin' Sticks threshold and identification test) were assessed initially, after one, 6, 12, 18 and 24 months. The changes in each parameter compared to baseline were analysed.

Results

Biologic therapy showed a significant improvement (p

Zitieren

APA

Gunder, N., Hummel, T., & Cuevas, M. (2024). Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data. Laryngo-Rhino-Otologie, 103(S 02 S 02), S315. https://doi.org/10.1055/s-0044-1785064

Vancouver

Gunder N, Hummel T, Cuevas M. Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S315. doi:10.1055/s-0044-1785064

BibTeX
@article{Gunder2024,
  author = {Gunder, Nadine and Hummel, Thomas and Cuevas, Mandy},
  title = {Effectiveness and safety of biologics in the treatment of severe chronic rhinosinusitis with polyposis (CRSwNP): real-world data},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S315},
  doi = {10.1055/s-0044-1785064}
}
Kostenlos starten →